全文获取类型
收费全文 | 1856篇 |
免费 | 122篇 |
国内免费 | 1篇 |
出版年
2023年 | 15篇 |
2022年 | 43篇 |
2021年 | 67篇 |
2020年 | 26篇 |
2019年 | 28篇 |
2018年 | 51篇 |
2017年 | 47篇 |
2016年 | 51篇 |
2015年 | 104篇 |
2014年 | 98篇 |
2013年 | 131篇 |
2012年 | 159篇 |
2011年 | 147篇 |
2010年 | 82篇 |
2009年 | 68篇 |
2008年 | 85篇 |
2007年 | 81篇 |
2006年 | 65篇 |
2005年 | 64篇 |
2004年 | 61篇 |
2003年 | 56篇 |
2002年 | 49篇 |
2001年 | 22篇 |
2000年 | 21篇 |
1999年 | 13篇 |
1998年 | 7篇 |
1997年 | 10篇 |
1996年 | 8篇 |
1995年 | 14篇 |
1994年 | 7篇 |
1992年 | 15篇 |
1991年 | 18篇 |
1990年 | 14篇 |
1989年 | 18篇 |
1988年 | 13篇 |
1987年 | 24篇 |
1986年 | 25篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1982年 | 8篇 |
1981年 | 7篇 |
1980年 | 7篇 |
1979年 | 13篇 |
1978年 | 14篇 |
1977年 | 11篇 |
1976年 | 7篇 |
1974年 | 11篇 |
1973年 | 12篇 |
1972年 | 6篇 |
1962年 | 5篇 |
排序方式: 共有1979条查询结果,搜索用时 15 毫秒
41.
Fatty acyl-coenzyme A is required for budding of transport vesicles from Golgi cisternae 总被引:16,自引:0,他引:16
We describe a new role for fatty acylation. Conditions were established under which vesicular transport from the cis to the medial Golgi compartment in vitro depends strongly upon the addition of a fatty acyl-coenzyme A, e.g., palmitoyl-CoA. Using an inhibitor of long-chain acyl-CoA synthetase, we demonstrate that the fatty acid has to be activated by CoA to stimulate transport. A nonhydrolyzable analog of palmitoyl-CoA competitively inhibits transport. Electron microscopy and biochemical studies show that fatty acyl-CoA is required for budding of (non-clathrin-) coated transport vesicles from Golgi cisternae and that budding is inhibited by the nonhydrolyzable analog. 相似文献
42.
Ferrets are widely used as animal models for studying influenza A viral pathogenesis and transmissibility. Human-adapted influenza A viruses primarily target the upper respiratory tract in humans (infection of the lower respiratory tract is observed less frequently), while in ferrets, upon intranasal inoculation both upper and lower respiratory tract are targeted. Viral tropism is governed by distribution of complex sialylated glycan receptors in various cells/tissues of the host that are specifically recognized by influenza A virus hemagglutinin (HA), a glycoprotein on viral surface. It is generally known that upper respiratory tract of humans and ferrets predominantly express α2→6 sialylated glycan receptors. However much less is known about the fine structure of these glycan receptors and their distribution in different regions of the ferret respiratory tract. In this study, we characterize distribution of glycan receptors going beyond terminal sialic acid linkage in the cranial and caudal regions of the ferret trachea (upper respiratory tract) and lung hilar region (lower respiratory tract) by multiplexing use of various plant lectins and human-adapted HAs to stain these tissue sections. Our findings show that the sialylated glycan receptors recognized by human-adapted HAs are predominantly distributed in submucosal gland of lung hilar region as a part of O-linked glycans. Our study has implications in understanding influenza A viral pathogenesis in ferrets and also in employing ferrets as animal models for developing therapeutic strategies against influenza. 相似文献
43.
44.
45.
46.
Ramya Krishnan Rahul Ravikumar Menon Naoto Tanaka Hans-Jürgen Busse Srinivasan Krishnamurthi Natarajan Rameshkumar 《PloS one》2016,11(3)
A novel yellow colony-forming bacterium, strain P3B162T was isolated from the pokkali rice rhizosphere from Kerala, India, as part of a project study aimed at isolating plant growth beneficial rhizobacteria from saline tolerant pokkali rice and functionally evaluate their abilities to promote plant growth under saline conditions. The novel strain P3B162T possesses plant growth beneficial traits such as positive growth on 1-aminocyclopropane-1-carboxylic acid (ACC), production of indole acetic acid (IAA) and siderophore. In addition, it also showed important phenotypic characters such as ability to form biofilm and utilization of various components of plant root exudates (sugars, amino acids and organic acids), clearly indicating its lifestyle as a plant rhizosphere associated bacterium. Taxonomically, the novel strain P3B162T was affiliated to the genus Arthrobacter based on the collective results of phenotypic, genotypic and chemotaxonomic analyses. Moreover, molecular analysis using 16S rRNA gene showed Arthrobacter globiformis NBRC 12137T, Arthrobacter pascens DSM 20545T and Arthrobacter liuii DSXY973T as the closely related phylogenetic neighbours, showing more than 98% 16S rRNA similarity values, whereas the recA gene analysis displayed Arthrobacter liuii JCM 19864T as the nearest neighbour with 94.7% sequence similarity and only 91.7% to Arthrobacter globiformis LMG 3813T and 88.7% to Arthrobacter pascens LMG 16255T. However, the DNA-DNA hybridization values between strain P3B162T, Arthrobacter globiformis LMG 3813T, Arthrobacter pascens LMG 16255T and Arthrobacter liuii JCM 19864T was below 50%. In addition, the novel strain P3B162T can be distinguished from its closely related type strains by several phenotypic characters such as colony pigment, tolerance to NaCl, motility, reduction of nitrate, hydrolysis of DNA, acid from sucrose, cell wall sugars and cell wall peptidoglycan structure. In conclusion, the combined results of this study support the classification of strain P3B162T as a novel Arthrobacter species and we propose Arthrobacter pokkalii sp.nov.as its name. The type strain is P3B162T (= KCTC 29498T = MTCC 12358T). 相似文献
47.
48.
49.
50.
Singh Ashutosh Singh Rahul Soloman Sarma Phulen Batra Gitika Joshi Rupa Kaur Hardeep Sharma Amit Raj Prakash Ajay Medhi Bikash 《中国病毒学》2020,35(3):290-304
The recent outbreak of coronavirus disease(COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) has already affected a large population of the world. SARS-CoV-2 belongs to the same family of severe acute respiratory syndrome coronavirus(SARS-CoV) and Middle East respiratory syndrome coronavirus(MERSCoV). COVID-19 has a complex pathology involving severe acute respiratory infection, hyper-immune response, and coagulopathy. At present, there is no therapeutic drug or vaccine approved for the disease. There is an urgent need for an ideal animal model that can reflect clinical symptoms and underlying etiopathogenesis similar to COVID-19 patients which can be further used for evaluation of underlying mechanisms, potential vaccines, and therapeutic strategies. The current review provides a paramount insight into the available animal models of SARS-CoV-2, SARS-CoV, and MERS-CoV for the management of the diseases. 相似文献